Results for the substance polysaccharide meningococcal vaccine

The meningococcal polysaccharide vaccine is used to prevent infections caused by Neisseria meningitidis, a bacterium that can cause meningitis and septicemia. The vaccine contains purified capsular polysaccharides from multiple serogroups of the bacterium, such as A, C, W, and Y, which stimulate the immune system to produce specific antibodies against these serogroups.

The vaccine is administered subcutaneously or intramuscularly, usually in a single dose, and is recommended for individuals traveling to endemic areas, those at increased risk of infection (such as students living in dormitories), or during outbreaks.

Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.

The meningococcal polysaccharide vaccine is an important preventive measure for reducing the incidence of meningococcal diseases, helping to protect vulnerable populations and prevent outbreaks.